|
|
Abstract: The use of somatostatin analogues is growing each year, especially for tumor imaging and treatment. In this scenario the numbers of radionuclides and the perspective of new one are quite promising. In this review we approach the possibilities and give an overview of the trends and possibilities in this area. Keywords: Radiopharmaceuticals, peptides, endocrinology, neuroendocrine tumors.Download Full Article |



